Cargando…

The effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cells

BACKGROUND: Technetium-99m methoxyisobutylisonitrile (Tc MIBI) is a substrate with the same uptake kinetics as doxorubicin. Multidrug resistance (MDR) is a mechanism that impedes chemotherapy of non-small cell lung cancer (NSCLC). We examined the effect of radiation exposure on MDR in NSCLC and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanno, Shohei, Utsunomiya, Keita, Kono, Yumiko, Tanigawa, Noboru, Sawada, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385263/
https://www.ncbi.nlm.nih.gov/pubmed/25853017
http://dx.doi.org/10.1186/s13550-015-0091-5
_version_ 1782365035025137664
author Kanno, Shohei
Utsunomiya, Keita
Kono, Yumiko
Tanigawa, Noboru
Sawada, Satoshi
author_facet Kanno, Shohei
Utsunomiya, Keita
Kono, Yumiko
Tanigawa, Noboru
Sawada, Satoshi
author_sort Kanno, Shohei
collection PubMed
description BACKGROUND: Technetium-99m methoxyisobutylisonitrile (Tc MIBI) is a substrate with the same uptake kinetics as doxorubicin. Multidrug resistance (MDR) is a mechanism that impedes chemotherapy of non-small cell lung cancer (NSCLC). We examined the effect of radiation exposure on MDR in NSCLC and the synergy between an MDR modulator, GG918, and radiation, using (99m)Tc MIBI in vitro and doxorubicin in vivo. METHODS: In vitro NSCLC cells (H1299) were exposed to radiation (3-, 6-, and 9-Gy-irradiated groups) alongside a not-irradiated (0 Gy) group. Technetium-99 metastable methoxyisobutylisonitrile ((99m)Tc MIBI) was administered to cell suspensions at 48 h after irradiation. Cell radioactivity was measured, and C(in)/C(out) ratios were calculated and compared. NSCLC cells were also subcutaneously transplanted into the left thigh of nude mice, which were subsequently raised for 2 weeks. Two groups of mice were used: mice exposed to irradiation (9-Gy-irradiated) and those that were not (not-irradiated). Doxorubicin was administered through the caudal vein at 48 h after the irradiation. Using an in vivo imaging system, intratumoural photon counts were measured. To determine the synergy between the MDR modulator and 3- or 6-Gy irradiation, the final GG918 concentration was determined: 0.1 μM (N-H, 3-H, and 6-H groups), 0.001 μM (N-L, 3-L, and 6-L groups), and 0 μM (N-0, 3-0, and 6-0 groups). C(in)/C(out) ratios were calculated and compared among the groups. RESULTS: C(in)/C(out) after 6- or 9-Gy irradiation was significantly higher than that of the not-irradiated group (0 Gy). In vivo, fluorescence photon counts were significantly higher in the tumours of 9-Gy-irradiated mice, up to 270 min after administration of doxorubicin, as compared to the not-irradiated mice. The C(in)/C(out) ratio in the N-H, 3-H, and 6-H groups was significantly higher than that in the N-0, 3-0, and 6-0 groups. There was no significant difference between C(in)/C(out) in the N-L group and that of the N-0 group. However, the C(in)/C(out) ratio in the 3-L and 6-L groups was significantly higher than that in the 3-0 and 6-0 groups. CONCLUSIONS: Irradiation decreased MDR in NSCLC cells. In combination with a low-dose MDR modulator, GG918, MDR transport function was synergistically reduced 48 h post-irradiation.
format Online
Article
Text
id pubmed-4385263
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-43852632015-04-07 The effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cells Kanno, Shohei Utsunomiya, Keita Kono, Yumiko Tanigawa, Noboru Sawada, Satoshi EJNMMI Res Original Research BACKGROUND: Technetium-99m methoxyisobutylisonitrile (Tc MIBI) is a substrate with the same uptake kinetics as doxorubicin. Multidrug resistance (MDR) is a mechanism that impedes chemotherapy of non-small cell lung cancer (NSCLC). We examined the effect of radiation exposure on MDR in NSCLC and the synergy between an MDR modulator, GG918, and radiation, using (99m)Tc MIBI in vitro and doxorubicin in vivo. METHODS: In vitro NSCLC cells (H1299) were exposed to radiation (3-, 6-, and 9-Gy-irradiated groups) alongside a not-irradiated (0 Gy) group. Technetium-99 metastable methoxyisobutylisonitrile ((99m)Tc MIBI) was administered to cell suspensions at 48 h after irradiation. Cell radioactivity was measured, and C(in)/C(out) ratios were calculated and compared. NSCLC cells were also subcutaneously transplanted into the left thigh of nude mice, which were subsequently raised for 2 weeks. Two groups of mice were used: mice exposed to irradiation (9-Gy-irradiated) and those that were not (not-irradiated). Doxorubicin was administered through the caudal vein at 48 h after the irradiation. Using an in vivo imaging system, intratumoural photon counts were measured. To determine the synergy between the MDR modulator and 3- or 6-Gy irradiation, the final GG918 concentration was determined: 0.1 μM (N-H, 3-H, and 6-H groups), 0.001 μM (N-L, 3-L, and 6-L groups), and 0 μM (N-0, 3-0, and 6-0 groups). C(in)/C(out) ratios were calculated and compared among the groups. RESULTS: C(in)/C(out) after 6- or 9-Gy irradiation was significantly higher than that of the not-irradiated group (0 Gy). In vivo, fluorescence photon counts were significantly higher in the tumours of 9-Gy-irradiated mice, up to 270 min after administration of doxorubicin, as compared to the not-irradiated mice. The C(in)/C(out) ratio in the N-H, 3-H, and 6-H groups was significantly higher than that in the N-0, 3-0, and 6-0 groups. There was no significant difference between C(in)/C(out) in the N-L group and that of the N-0 group. However, the C(in)/C(out) ratio in the 3-L and 6-L groups was significantly higher than that in the 3-0 and 6-0 groups. CONCLUSIONS: Irradiation decreased MDR in NSCLC cells. In combination with a low-dose MDR modulator, GG918, MDR transport function was synergistically reduced 48 h post-irradiation. Springer Berlin Heidelberg 2015-03-17 /pmc/articles/PMC4385263/ /pubmed/25853017 http://dx.doi.org/10.1186/s13550-015-0091-5 Text en © Kanno et al.; licensee Springer. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Original Research
Kanno, Shohei
Utsunomiya, Keita
Kono, Yumiko
Tanigawa, Noboru
Sawada, Satoshi
The effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cells
title The effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cells
title_full The effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cells
title_fullStr The effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cells
title_full_unstemmed The effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cells
title_short The effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cells
title_sort effect of radiation exposure on multidrug resistance: in vitro and in vivo studies using non-small lung cancer cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385263/
https://www.ncbi.nlm.nih.gov/pubmed/25853017
http://dx.doi.org/10.1186/s13550-015-0091-5
work_keys_str_mv AT kannoshohei theeffectofradiationexposureonmultidrugresistanceinvitroandinvivostudiesusingnonsmalllungcancercells
AT utsunomiyakeita theeffectofradiationexposureonmultidrugresistanceinvitroandinvivostudiesusingnonsmalllungcancercells
AT konoyumiko theeffectofradiationexposureonmultidrugresistanceinvitroandinvivostudiesusingnonsmalllungcancercells
AT tanigawanoboru theeffectofradiationexposureonmultidrugresistanceinvitroandinvivostudiesusingnonsmalllungcancercells
AT sawadasatoshi theeffectofradiationexposureonmultidrugresistanceinvitroandinvivostudiesusingnonsmalllungcancercells
AT kannoshohei effectofradiationexposureonmultidrugresistanceinvitroandinvivostudiesusingnonsmalllungcancercells
AT utsunomiyakeita effectofradiationexposureonmultidrugresistanceinvitroandinvivostudiesusingnonsmalllungcancercells
AT konoyumiko effectofradiationexposureonmultidrugresistanceinvitroandinvivostudiesusingnonsmalllungcancercells
AT tanigawanoboru effectofradiationexposureonmultidrugresistanceinvitroandinvivostudiesusingnonsmalllungcancercells
AT sawadasatoshi effectofradiationexposureonmultidrugresistanceinvitroandinvivostudiesusingnonsmalllungcancercells